Related Experiment Video

Updated: May 13, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

A new COL3A1 mutation in Ehlers-Danlos syndrome type IV

Johanna Eder, Franco Laccone, Marianne Rohrbach

    Experimental Dermatology
    |March 16, 2013
    PubMed

    Insights

    Ehlers-Danlos syndrome type IV (EDS IV), a connective tissue disorder, can manifest with severe peripheral artery occlusive disease (PAOD). A novel COL3A1 mutation was identified in a patient with EDS IV and PAOD, suggesting a potential genotype-phenotype correlation.

    Area of Science:

    • Genetics
    • Vascular Biology
    • Connective Tissue Diseases

    Background:

    • Ehlers-Danlos syndrome type IV (EDS IV) is a rare autosomal dominant connective tissue disorder.
    • It is characterized by mutations in the COL3A1 gene, leading to fragile connective tissues and increased risk of arterial, intestinal, and uterine ruptures.
    • Typical manifestations include vascular complications and premature death.

    Observation:

    • A 28-year-old female patient presented with symptoms consistent with EDS IV.
    • She also exhibited severe peripheral artery occlusive disease (PAOD) and subtotal stenosis of the abdominal aorta.
    • Ultrastructural analysis of her skin biopsy showed abnormal dermal collagen fiber morphology and distribution.

    Findings:

    • COL3A1 gene sequencing revealed a novel mutation (c.2465G>C; p.G822A) in exon 36.
    • This mutation is associated with the patient's EDS IV symptoms and severe PAOD.
    • The findings suggest a potential link between this specific COL3A1 mutation and vascular pathology.

    Implications:

    • Peripheral artery occlusive disease (PAOD) may be an underrecognized manifestation of Ehlers-Danlos syndrome type IV (EDS IV).
    • Further research is needed to determine the prevalence of PAOD in EDS IV patients and its underlying molecular pathology.
    • Establishing genotype-phenotype correlations is crucial for better understanding and managing EDS IV patients with vascular complications.

    More Related Videos

    Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

    Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

    Published on: August 8, 2022

    Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease09:34

    Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

    Published on: April 4, 2018

    Related Concept Videos

    Type IV Collagen of Basal Lamina01:05

    Type IV Collagen of Basal Lamina

    Type IV collagen is a 400 nm long, network-forming collagen that acts as a barrier between the epithelial and endothelial cells. Type IV collagen  forms the backbone of the basement membrane by scaffolding with laminin, entactin, proteoglycans, and fibronectin. Apart from rendering structural support to the basement membrane, it also helps entail signaling potentials necessary for both pathological and physiological functions.
    A type IV collagen molecule has six alpha chains which can exist in...
    Fibril-associated Collagen01:11

    Fibril-associated Collagen

    Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
    For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
    Mutations01:35

    Mutations

    Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
    Chromosomal Alterations Are Large-Scale Mutations
    While point mutations are changes in a single nucleotide in...
    Mutations01:39

    Mutations

    Overview
    Mutations01:39

    Mutations

    Overview
    Point and Frameshift Mutations01:30

    Point and Frameshift Mutations

    Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...